Literature DB >> 1371014

Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.

H Ben-Artzi1, E Zeelon, M Gorecki, A Panet.   

Abstract

Early events in the retroviral replication cycle include the conversion of viral genomic RNA into linear double-stranded DNA. This process is mediated by the reverse transcriptase (RT), a multifunctional enzyme that possesses RNA-dependent DNA polymerase, DNA-dependent DNA polymerase, and RNase H activities. In the course of studies of a recombinant RT of human immunodeficiency virus type 1 (HIV-1), we observed an additional, unexpected activity of the enzyme. The purified RT catalyzes a specific cleavage in HIV-1 RNA hybridized to tRNALys, the primer for HIV-1 reverse transcription. The cleavage at the primer binding site (PBS) of HIV RNA is dependent on the double-stranded structure of the HIV RNA-tRNALys complex. This RNase activity appears to be distinct from the RNase H activity of HIV-1 RT, as the substrate specificity and the products of the two activities are different. Moreover, Escherichia coli RNase H and avian myeloblastosis virus RT are unable to cleave the HIV RNA-tRNALys complex. We refer to this unusual activity as RNase D. Two lines of evidence indicate that the specific RNase D activity is an integral part of recombinant HIV RT. The specific RNase D activity comigrates with the other RT activities, DNA polymerase, and RNase H upon filtration on a Superose 6 gel column or chromatography on a phosphocellulose column. Moreover, three recombinant HIV-1 RT preparations expressed and purified in different laboratories by various procedures exhibit RNase D activity. Sequence analysis indicated that RNase D activity cleaves the substrate HIV-1 RNA-tRNALys at two distinct sites within the PBS sequence 5'-UGGCGCCCGA decreases ACAG decreases GGAC-3'. The sequence specificity of RNase D activity suggests that it might be involved in two stages during the reverse transcription process: displacement of the PBS to enable copying of tRNALys sequences into plus-strand DNA or to facilitate the second template switch, which was postulated to occur at the PBS sequence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371014      PMCID: PMC48358          DOI: 10.1073/pnas.89.3.927

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Specificities involved in the initiation of retroviral plus-strand DNA.

Authors:  G X Luo; L Sharmeen; J Taylor
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 2.  Retroviral reverse transcriptase: synthesis, structure, and function.

Authors:  S P Goff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

4.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Cloning and expression of the gene for bacteriophage T7 RNA polymerase.

Authors:  P Davanloo; A H Rosenberg; J J Dunn; F W Studier
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase).

Authors:  A Panet; W A Haseltine; D Baltimore; G Peters; F Harada; J E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

7.  Ribonuclease H activities associated with viral reverse transcriptases are endonucleases.

Authors:  M S Krug; S L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

Authors:  H E Gendelman; W Phelps; L Feigenbaum; J M Ostrove; A Adachi; P M Howley; G Khoury; H S Ginsberg; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity.

Authors:  O Schatz; J Mous; S F Le Grice
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.

Authors:  C Barat; V Lullien; O Schatz; G Keith; M T Nugeyre; F Grüninger-Leitch; F Barré-Sinoussi; S F LeGrice; J L Darlix
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  14 in total

1.  Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases.

Authors:  H Ben-Artzi; E Zeelon; S F Le-Grice; M Gorecki; A Panet
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

2.  Reversion of a Moloney murine leukemia virus RNase H mutant at a second site restores enzyme function and infectivity.

Authors:  S W Blain; W A Hendrickson; S P Goff
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

3.  Redesignation of the RNase D activity associated with retroviral reverse transcriptase as RNase H.

Authors:  Z Hostomsky; S H Hughes; S P Goff; S F Le Grice
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.

Authors:  J J DeStefano; L M Mallaber; P J Fay; R A Bambara
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

Review 5.  In vitro and in vivo action of antisense RNA.

Authors:  W Nellen; G Sczakiel
Journal:  Mol Biotechnol       Date:  1996-08       Impact factor: 2.695

6.  The orientation of binding of human immunodeficiency virus reverse transcriptase on nucleic acid hybrids.

Authors:  J J DeStefano
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

7.  Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Authors:  J S Smith; M J Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  RNase D, a reported new activity associated with HIV-1 reverse transcriptase, displays the same cleavage specificity as Escherichia coli RNase III.

Authors:  Z Hostomsky; G O Hudson; S Rahmati; Z Hostomska
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

9.  Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.

Authors:  V Gopalakrishnan; J A Peliska; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor.

Authors:  D B Olsen; S S Carroll; J C Culberson; J A Shafer; L C Kuo
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.